Treatment for Attention-Deficit/Hyperactivity Disorder in Adults.
- Author:
Jaewon YANG
1
;
Ji Hoon KIM
;
Jae Won KIM
;
Jeewook CHOI
;
Hyun Ju HONG
;
Yoo Sook JOUNG
Author Information
1. Department of Psychiatry, Korea University Ansan Hospital, Korea University Research Institute of Mental Health, Ansan, Korea.
- Publication Type:Original Article
- Keywords:
Adult Attention-Deficit/Hyperactivity Disorder;
Pharmacotherapy;
Stimulants;
Non-Stimulants
- MeSH:
Adult;
Bupropion;
Comorbidity;
Humans;
Propylamines;
Atomoxetine Hydrochloride
- From:Journal of the Korean Academy of Child and Adolescent Psychiatry
2012;23(Suppl):S72-S89
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This review examined the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults. It briefly addresses the issues about the cause of hospital visit, diagnosis, and impact of disease, specific to adults. The article focused on the evidence regarding the efficacy and tolerability of short- and long-acting stimulant medications, as well as the non-stimulant medications such as atomoxetine and bupropion in the treatment of the adult ADHD. Generally speaking, variability in diagnostic criteria, dosing parameters and response rates between the various studies were considerable. The aggregated literature shows that both the stimulants and non-stimulants had clinically significant beneficial effect on treating ADHD in adults. Special attention is given to the pharmacological treatment for patients with adult ADHD and various comorbidities. In summary, medications are effective and combined medication and psychosocial treatment is the most beneficial treatment option for most adult patients with ADHD.
